The World Health Organization (WHO) has taken a major step toward integrating precision medicine into global healthcare systems following the adoption of Resolution EB158.R2 at the 79th World Health Assembly. The resolution establishes a strategic framework to guide countries in implementing precision medicine in ways that are effective, ethical, equitable, and accessible to all populations.
Precision medicine uses clinical, molecular, and genomic information to tailor healthcare interventions to the specific characteristics of individual patients. By enabling more accurate prevention, diagnosis, and treatment approaches, this model has the potential to improve outcomes across a wide range of health conditions, including cancer, rare diseases, infectious diseases, maternal and child health challenges, mental health disorders, and noncommunicable diseases.
The resolution reflects the increasing importance of genomics, digital health technologies, and artificial intelligence in modern healthcare. WHO Member States have committed to promoting personalized healthcare through the integration of genomic data and biomarkers, expanding equitable access to advanced medical technologies, strengthening national infrastructure and workforce capacity, and enhancing regulatory frameworks to ensure ethical standards, quality assurance, and data protection.
A key focus of the initiative is addressing health inequalities. WHO has highlighted concerns that many populations, particularly those in low- and middle-income countries, remain underrepresented in genomic research and health data. Without targeted action, these gaps could limit the effectiveness of precision medicine and potentially widen existing healthcare disparities. The new strategy aims to ensure that the benefits of genomic innovation are shared more broadly across different populations and regions.
To support implementation, WHO plans to map existing policies, frameworks, and best practices while conducting extensive consultations with governments, researchers, healthcare providers, and other stakeholders. These efforts will contribute to the development of a Global Strategy on Precision Medicine designed to guide countries in adopting approaches that reflect local needs and capacities while maintaining international standards.
In the Americas, the initiative aligns with ongoing efforts by the Pan American Health Organization (PAHO) to strengthen genomic health capabilities. Recent regional activities have focused on expanding access to genomic knowledge and technologies, fostering collaboration among experts, and developing resources that support precision health initiatives across the region.
Despite growing momentum, significant challenges remain. Health systems continue to face limitations in genomic infrastructure, data management capabilities, ethical data-sharing frameworks, and access to specialized expertise. Expanding genomic representation of diverse populations, including Indigenous communities, and building sustainable genomic health services are considered essential steps for achieving equitable implementation.
The WHO resolution marks an important milestone in the evolution of healthcare, positioning precision medicine as a key component of future health systems. By encouraging innovation while emphasizing equity, ethics, and sustainability, the initiative aims to help countries deliver more personalized, effective, and people-centered healthcare while advancing progress toward universal health coverage.
